A meta-analysis of forty-six randomized controlled trials showed that probiotics and synbiotics administration reduced fasting plasma glucose, hemoglobin A1c, insulin serum levels, and insulin resistance in patients with prediabetes and type 2 diabetes mellitus [24]. The gene discussed is INS; the disease is type 2 diabetes mellitus.